Analyst Ratings For Allena Pharmaceuticals (NASDAQ:ALNA) (NASDAQ:ALNA)
Today, Credit Suisse Group lowered its price target on Allena Pharmaceuticals (NASDAQ:ALNA) (NASDAQ:ALNA) to $21.00 per share.
Some recent analyst ratings include
- 3/28/2018-Wedbush Reiterated Rating of Outperform.
- 11/27/2017-Cowen initiated coverage with a Outperform rating.
- 11/27/2017-Jefferies Group initiated coverage with a Buy rating.
- On 11/6/2017 Bessemer Venture Partners Vii, Major Shareholder, bought 36,000 with an average share price of $14.00 per share and the total transaction amounting to $504,000.00.
- On 11/6/2017 James N Topper, Director, bought 500,000 with an average share price of $14.00 per share and the total transaction amounting to $7,000,000.00.
Recent Trading Activity for Allena Pharmaceuticals (NASDAQ:ALNA) (NASDAQ:ALNA)
Shares of Allena Pharmaceuticals (NASDAQ:ALNA) closed the previous trading session at 10.22 up +0.26 2.61% with 9.989999771118164 shares trading hands.